Dual therapy with dabigatran and clopidogrel preferred after PCI for patients with AF (RE-DUAL PCI)

Dual therapy with dabigatran and clopidogrel preferred after PCI for patients with AF (RE-DUAL PCI) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Dual therapy with dabigatran and clopidogrel preferred after PCI for patients with AF (RE-DUAL PCI) ID - 1314413 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314413/all/Dual_therapy_with_dabigatran_and_clopidogrel_preferred_after_PCI_for_patients_with_AF__RE_DUAL_PCI_ PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -